124 related articles for article (PubMed ID: 34699702)
1. Prevalence and Predictors of Impaired Glucose Tolerance and Diabetes Mellitus Type 2 in Patients with Polycystic Ovary Syndrome.
Krstevska B; Mishevska SJ; Nakova VV; Serafimoski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2021 Oct; 42(2):61-70. PubMed ID: 34699702
[No Abstract] [Full Text] [Related]
2. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study.
Celik C; Tasdemir N; Abali R; Bastu E; Yilmaz M
Fertil Steril; 2014 Apr; 101(4):1123-8.e1. PubMed ID: 24502891
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann DA; Barnes RB; Rosenfield RL; Cavaghan MK; Imperial J
Diabetes Care; 1999 Jan; 22(1):141-6. PubMed ID: 10333916
[TBL] [Abstract][Full Text] [Related]
4. Assessment of insulin resistance and impaired glucose tolerance in lean women with polycystic ovary syndrome.
Stovall DW; Bailey AP; Pastore LM
J Womens Health (Larchmt); 2011 Jan; 20(1):37-43. PubMed ID: 21194310
[TBL] [Abstract][Full Text] [Related]
5. Dysglycemia screening with oral glucose tolerance test in adolescents with polycystic ovary syndrome and relationship with obesity.
Gupta J; Antal Z; Mauer E; Gerber LM; An A; Censani M
BMC Endocr Disord; 2022 Jul; 22(1):180. PubMed ID: 35842601
[TBL] [Abstract][Full Text] [Related]
6. Assessment of impaired glucose tolerance prevalence with hemoglobin A₁c and oral glucose tolerance test in 252 Turkish women with polycystic ovary syndrome: a prospective, controlled study.
Celik C; Abali R; Bastu E; Tasdemir N; Tasdemir UG; Gul A
Hum Reprod; 2013 Apr; 28(4):1062-8. PubMed ID: 23335611
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of Type 2 diabetes is not increased in normal-weight women with PCOS.
Pelanis R; Mellembakken JR; Sundström-Poromaa I; Ravn P; Morin-Papunen L; Tapanainen JS; Piltonen T; Puurunen J; Hirschberg AL; Fedorcsak P; Andersen M; Glintborg D
Hum Reprod; 2017 Nov; 32(11):2279-2286. PubMed ID: 29040530
[TBL] [Abstract][Full Text] [Related]
8. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of insulin resistance and prediction of glucose intolerance and type 2 diabetes mellitus in women with polycystic ovary syndrome.
Vrbikova J; Dvorakova K; Grimmichova T; Hill M; Stanicka S; Cibula D; Bendlova B; Starka L; Vondra K
Clin Chem Lab Med; 2007; 45(5):639-44. PubMed ID: 17484627
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome.
Weerakiet S; Srisombut C; Bunnag P; Sangtong S; Chuangsoongnoen N; Rojanasakul A
Int J Gynaecol Obstet; 2001 Nov; 75(2):177-84. PubMed ID: 11684113
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.
Flannery CA; Rackow B; Cong X; Duran E; Selen DJ; Burgert TS
Pediatr Diabetes; 2013 Feb; 14(1):42-9. PubMed ID: 22925367
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and risk factors for glucose intolerance in young Korean women with polycystic ovary syndrome.
Lee H; Oh JY; Sung YA; Chung H; Cho WY
Endocrine; 2009 Oct; 36(2):326-32. PubMed ID: 19688613
[TBL] [Abstract][Full Text] [Related]
13. Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.
Sieminska L; Marek B; Kos-Kudla B; Niedziolka D; Kajdaniuk D; Nowak M; Glogowska-Szelag J
J Endocrinol Invest; 2004 Jun; 27(6):528-34. PubMed ID: 15717649
[TBL] [Abstract][Full Text] [Related]
14. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
Moran LJ; Misso ML; Wild RA; Norman RJ
Hum Reprod Update; 2010; 16(4):347-63. PubMed ID: 20159883
[TBL] [Abstract][Full Text] [Related]
15. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
Ferjan S; Janez A; Jensterle M
Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of abnormalities of glucose metabolism in patients with polycystic ovary syndrome.
Barcellos CR; Rocha MP; Hayashida SA; Nery M; Marcondes JA
Arq Bras Endocrinol Metabol; 2007 Jun; 51(4):601-5. PubMed ID: 17684622
[TBL] [Abstract][Full Text] [Related]
17. Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome.
Ehrmann DA; Kasza K; Azziz R; Legro RS; Ghazzi MN;
J Clin Endocrinol Metab; 2005 Jan; 90(1):66-71. PubMed ID: 15507516
[TBL] [Abstract][Full Text] [Related]
18. Changes in glucose tolerance with metformin treatment in polycystic ovary syndrome: a retrospective analysis.
Sharma ST; Wickham EP; Nestler JE
Endocr Pract; 2007; 13(4):373-9. PubMed ID: 17669713
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for glucose intolerance in Danish women with polycystic ovary syndrome.
Trolle B; Lauszus FF
Acta Obstet Gynecol Scand; 2005 Dec; 84(12):1192-6. PubMed ID: 16305707
[TBL] [Abstract][Full Text] [Related]
20. Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome.
Moran LJ; Teede HJ; Noakes M; Clifton PM; Norman RJ; Wittert GA
J Endocrinol Invest; 2013 Dec; 36(11):1004-10. PubMed ID: 23812344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
